• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS B 101 HBA1C TEST; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS B 101 HBA1C TEST; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Model Number B 101 HBA1C
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/13/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The investigation is ongoing.
 
Event Description
The initial reporter received questionable result hemoglobin a1c results for three patient samples from cobas b 101 instrument serial number (b)(4).The samples were repeated in another laboratory with an unknown method.Patient 1: b101 result was 7.9% and the repeat result was 7.2%.Patient 2: b101 result was 7.3% and the repeat result was 6.5%.Patient 3: b101 result was 8.3% and the repeat result was 7.4%.The questionable results were reported outside of the laboratory.
 
Manufacturer Narrative
The customer did not return any materials for investigation.Without these materials to investigate, a specific root cause could not be determined.Retention material of cobas b101 hba1c lot 931043-01 was tested with whole blood measurements and held against target values obtained from a tosoh g8 instrument: a) eight low whole blood samples were measured with retention material of cobas b101 hba1c lot 931043-01 on a retention cobas b101 instrument.B) eight middle whole blood samples were measured with retention material of cobas b101 hba1c lot 931043-01 on a retention cobas b101 instrument.The product meets specification.Retention material testing and manufacturer final product inspection were successful.The retention material measurements on the retention cobas b101 instrument showed no hba1c deviation compared to tosoh g8.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS B 101 HBA1C TEST
Type of Device
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9429521
MDR Text Key218729623
Report Number1823260-2019-04302
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
PMA/PMN Number
K163633
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 12/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberB 101 HBA1C
Device Catalogue Number06378676190
Device Lot Number931043-012
Was Device Available for Evaluation? Yes
Date Manufacturer Received11/14/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-